Yoo Ah In Being Canceled by Brands Amid Drug Investigation? Here’s What Happened

Tags
Yoo Ah In
Yoo Ah In Controversy

Amid the investigation into Yoo Ah In's drug issue, brands are keeping a close eye on the ongoing probe after he was accused of using an illegal substance.

The industry was shocked the prolific actor went under investigation for the illegal use of propofol, a kind of sedative used in hospital settings by trained anesthetists. The substance will help the patient feel relaxed or asleep before and during surgery.

Yoo Ah In's Drug Case: From Propofol Probe to Marijuana Use

As parties wait for the result of Yoo Ah In's drug test, brands seemed to drop the actor as their advertisement model.

According to an outlet, Seoul Finance reported that the pharmaceutical company, Chong Kun Dang Health, has deleted all photos of their endorsements featuring the "Seoul Vibe" star including the Kakao Talk gift-giving channel where its product Imvita

It comes after the news regarding the actor's alleged propofol was publicized and the next day, an advertisement with Yoo Ah In's face was reportedly taken down.

READ MORE: Korean Heartthrobs, A-listers Returning to Big Screen: Hyun Bin, Yoo Ah In, Joo Won, More

Meanwhile, a representative from Chong Kun Dang Health explained "The contract period is not disclosed to each other for contractual reasons."

Adding to the list is the ramen brand Ottogi. After the news broke, all of Yoo Ah In's commercial on YouTube was changed to private.

The same goes for the clothing brand Musinsa, a fashion company that tapped the actor as their brand ambassador.

Yoo Ah In's CF for the brand was also changed to private at the height of the controversy.

Besides his ongoing endorsements, Yoo Ah In's upcoming dramas are also predicted to be affected by the issue.

That is because there will be changes regarding the schedule as the investigation continues.

IN CASE YOU MISSED IT: Is 'Seoul Vibe' Sequel Possible? Here's What We Know So Far
KDramastars owns this article
Written by Geca Wills

Join the Discussion

Latest News

Real Time Analytics